Fresh analysis reveals that patients who discontinue popular GLP-1 drugs like Wegovy and Mounjaro may regain shed pounds much more quickly than those who halt conventional lifestyle regimens.
Published data in a major health publication demonstrates that while obese individuals often shed substantial amounts of their total mass while using the jabs, the weight comes back at an average rate of nearly a kilo each month once they quit.
"People using such drugs should be informed of the danger of quick rebound weight gain when the therapy is stopped," cautioned lead investigator Dr. Susan Jebb.
This pace of recovery implies a reversion to original weight within about 18 months.
Analyzing Therapies
The analysis, which looked at 37 of trials involving thousands of participants, compared the effects of the injectable medications with conventional dieting.
Researchers point out that people who shed pounds through lifestyle changes alone usually have a more gradual creep back—approximately 100 grams monthly—once they finish.
The Reason for the Rapid Regain
Doctors suggest the mode of action of the jabs explains the amplified rebound.
These medications copy a natural hormone called glucagon-like peptide-1, which moderates appetite.
"Artificially providing the hormone levels far above than normal may cause the body to generate a reduced amount of its endogenous GLP-1, and could lessen sensitivity to its effects," explained Dr. Adam Collins, a nutrition specialist.
"Stopping of this hormone supplement means appetite is unsuppressed, making excessive eating far more likely."
An Ongoing Condition?
The NHS recommend the jabs for people with obesity-related medical conditions, alongside prescribed lifestyle changes.
Professionals say that, given the significant potential of relapse, the therapy is often life-long.
This opinion is supported by pharmaceutical companies, who state that the results "underscore the chronic character of obesity," similar to managing conditions like hypertension.
Patient Testimonies
Individuals who have come off the medication explain a powerful resurgence of cravings.
"I experienced something activating and I was suddenly extremely hungry," said a patient.
The struggle is compounded if patients have not established sustainable dietary or behavioural changes during treatment.
Significant Interest
Figures indicate that a significant number of adults in the UK have tried these injections in the past year, with demand continuing to grow.
- Adoption is higher among females than men.
- The middle-aged demographic shows the greatest level of interest.
- Many obtain the drugs through private prescriptions rather than the NHS.
In conclusion, researchers emphasize that while these medications are potent agents for shedding pounds, they are not a permanent solution and lasting health benefits hinges on integrated lifestyle management.
